Migraine drug takes on pancreatic cancer in early trial
Disease control
Not yet recruiting
This early-phase trial tests whether adding the migraine drug rimegepant to standard chemotherapy can help people with metastatic pancreatic cancer. About 30 adults who have not had prior treatment will receive the combination. Researchers will track how long the cancer stays und…
Phase: PHASE1, PHASE2 • Sponsor: Xiuchao Wang • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC